Please login to the form below

Not currently logged in
Email:
Password:

payer

This page shows the latest payer news and features for those working in and with pharma, biotech and healthcare.

Awesome abstraction

Awesome abstraction

She wanted to know how to adapt the commercial operating model of her firm to the changing conditions of the market, especially the changing roles of payers and prescribers.

Latest news

More from news
Approximately 5 fully matching, plus 577 partially matching documents found.

Latest Intelligence

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    Long-term sustainability. Deals must be win-win because it is important to create a true long-term partnership between payers and industry. ... Payers must positively want to use new treatments and industry must feel its investment is rewarded.

  • Measuring what matters: how to create the right KPIs for your brand, launch and portfolio Measuring what matters: how to create the right KPIs for your brand, launch and portfolio

    The pharmaceutical industry is continuing its ‘disruption phase’ and therefore measurement of patient/physician/payer attitudes, engagement, behaviour as well as other activity, investment and competitive performance measures are more important

  • New strategic blueprint: the new first questions New strategic blueprint: the new first questions

    Discussions on price and value quickly move from boardroom to conference room where they are disclosed earlier and earlier to payer partners. ... In the year ahead, more companies will create cross clinical-commercial teams to focus on building stronger

  • A market-adapted agile approach to launch excellence A market-adapted agile approach to launch excellence

    relevance. 2. Less white space product differentiation. In crowded disease areas where compounds may show only incremental benefit, payers often make cross-product comparisons, differentiating and restricting treatment access.

  • It started with a miss It started with a miss

    Companies can sometimes become so focused on the data and the science that they forget to think about what matters to the doctor, the patient or the payer. ... Definitions of value will obviously differ from customer to customer – payers, patients,

More from intelligence
Approximately 5 fully matching, plus 231 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 13 fully matching, plus 132 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics